Tandemact

· CHEPLAPHARM Arzneimittel GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tandemact, covering 2023-09-13 to 2023-09-13. Get the full timeline:

Most recent: EMA Authorised: Tandemact (pioglitazone;glimepiride) — CHEPLAPHARM Arzneimittel GmbH